Clinical Trial Update: Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document describes a Phase 1/2 clinical trial evaluating the combination of chemotherapy and celecoxib in patients with advanced non-small cell lung cancer,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Northwestern University | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED